Diethyl 2-methyl-2-[4-(oxan-2-yloxy)butyl]propanedioate | 859437-26-6

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: Diethyl 2-methyl-2-[4-(oxan-2-yloxy)butyl]propanedioate
• CAS: 859437-26-6
• 化学式: C₁₇H₃₀O₆
• 分子量: 330.422
• InChiKey: HGMLHDFXLHJQRZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  23
• 可旋转键数：
  12
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  71.1
• 氢给体数：
  0
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  Diethyl 2-methyl-2-[4-(oxan-2-yloxy)butyl]propanedioate 在 potassium fluoride 、 4-甲基苯磺酸吡啶 、 potassium carbonate 、 三乙胺 、 4,7,13,16,21,24-六氧-1,10-二氮双环[8.8.8]二十六烷 作用下， 以 乙醇 为溶剂， 反应 1.0h， 生成 diethyl 2-(4-fluorobutyl)-2-methylmalonate
  参考文献：
  名称：

  WO2008/81447

  摘要：

  公开号：
• 作为产物：
  描述：

  3,4-二氢-2H-吡喃 在 potassium iodide 4-甲基苯磺酸吡啶 、 sodium hydride 作用下， 以 二氯甲烷 为溶剂， 反应 10.0h， 生成 Diethyl 2-methyl-2-[4-(oxan-2-yloxy)butyl]propanedioate
  参考文献：
  名称：

  WO2008/81447

  摘要：

  公开号：

文献信息

• Perturbed membrane-binding compounds and methods of using the same
  申请人：Ziv Ilan

  公开号：US20050158239A1

  公开（公告）日：2005-07-21

  The present invention relates to compounds that selectively bind to cells undergoing perturbations and alterations of their normal plasma membrane organization, such as cells undergoing apoptosis or activated platelets. The invention further provides methods for utilizing said compounds in medical practice, for diagnostic and therapeutic purposes.

  本发明涉及选择性结合于正在经历扰动和改变其正常细胞膜组织的细胞的化合物，例如正在进行凋亡或激活的血小板。该发明进一步提供了利用这些化合物在医学实践中进行诊断和治疗的方法。
• Perturbed Membrane-Binding Compounds And Methods Of Using The Same
  申请人：Ziv Ilan

  公开号：US20080279774A1

  公开（公告）日：2008-11-13

  The present invention relates to compounds that selectively bind to cells undergoing perturbations and alterations of their normal plasma membrane organization, such as cells undergoing apoptosis or activated platelets. The invention further provides methods for utilizing said compounds in medical practice, for diagnostic and therapeutic purposes.
• COMPOUNDS AND METHODS FOR DETECTION OF CELLS
  申请人：Shirvan Anat

  公开号：US20100035296A1

  公开（公告）日：2010-02-11

  The invention relates to compounds comprising an ester group for the detection in vivo of cells undergoing cell death (“dying cells”) such as, for example, cells undergoing apoptosis. These compounds are selectively retained in dying cells relative to normal cells. Thus, the compounds may be used in the detection, diagnosis and treatment of clinical conditions manifested by a cell death process.
• PERTURBED MEMBRANE-BINDING COMPOUNDS AND METHODS OF USING THE SAME
  申请人：ZIV Ilan

  公开号：US20110257434A1

  公开（公告）日：2011-10-20

  The invention relates to compounds that selectively bind to cells undergoing perturbations and alterations of their normal plasma membrane organization, i.e., cells undergoing cell death, apoptotic cells or activated platelets. The invention further provides methods for utilizing the compounds in medical practice, for diagnostic and therapeutic purposes.
• US7270799B2
  申请人：——

  公开号：US7270799B2

  公开（公告）日：2007-09-18